U.S. Court of Appeals for the Federal Circuit, 2022

United Therapeutics Corporation v. Liquidia Technologies, Inc.

United Therapeutics Corporation v. Liquidia Technologies, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided November 18, 2022
United Therapeutics Corporation v. Liquidia Technologies, Inc.

Opinion

Case: 22-2133 Document: 28 Page: 1 Filed: 11/18/2022

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit UNITED THERAPEUTICS CORPORATION, Appellant v. LIQUIDIA TECHNOLOGICS, INC., Appellee

2022-2133

Appeal from the U n i t e d S t a t e s Patent and Trademark Office, Patent Trial and Appeal Board in IPR2020-00770. -------------------------------------------------- LIQUIDIA TECHNOLOGICS, INC., Appellant v.

UNITED THERAPEUTICS CORPORATION, Appellee

2022-2174 Case: 22-2133 Document: 28 Page: 2 Filed: 11/18/2022

2 BRUMFIELD V. IBG LLC

Appeal from the U n i t e d S t a t e s Patent and Trademark Office, Patent Trial and Appeal Board in IPR2020-00770.

ON MOTION

ORDER Upon consideration of the party’s motion to voluntarily dismiss Appeal No. 2022-2174, IT IS ORDERED THAT: (1) The motion is granted. Appeal No. 2022-2174 is DISMISSED under Fed. R. App. P. 42 (b). (2) Each side shall bear their own costs with respect to Appeal No. 2022-2174. (3) Appeal No. 2022-2174 is deconsolidated from Appeal No. 2022-2133, and the revised caption is reflected above.

November 18, 2022 FOR THE COURT Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

ISSUED AS A MANDATE (only as to Appeal No. 2022-2174): November 18, 2022

Case-law data current through December 31, 2025. Source: CourtListener bulk data.